Filter
750
Filtered Results: 750
Text search:
drug
dosing
Featured
Recommendations
104
New Publications
198
Language
Document type
No document type
435
Guidelines
160
Studies & Reports
82
Manuals
25
Training Material
16
Fact sheets
14
Strategic & Response Plan
10
Situation Updates
3
Resource Platforms
3
App
1
Online Courses
1
Countries / Regions
India
49
South Africa
34
Kenya
24
Tanzania
22
Ethiopia
18
Global
16
Zambia
14
Uganda
12
Africa
12
Rwanda
11
Nepal
10
Nigeria
8
Ghana
8
Namibia
8
Sierra Leone
7
Malawi
7
Western and Central Europe
7
Zimbabwe
6
Bangladesh
6
Myanmar / Burma
6
Philippines
5
Liberia
4
USA
4
South Sudan
4
Cambodia
4
Eswatini/ Swaziland
3
Lesotho
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
2
Syria
2
Argentina
2
Ukraine
2
Botswana
2
West and Central Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Burkina Faso
1
Cameroon
1
Haiti
1
Pakistan
1
Iraq
1
Germany
1
Thailand
1
Gambia
1
Indonesia
1
Sudan
1
Benin
1
Brazil
1
Angola
1
East and Southern Africa
1
Western Pacific Region
1
Venezuela
1
Eastern Europe
1
Albania
1
Canada
1
Tajikistan
1
Russia
1
Georgia
1
North America
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
153
Women & Child Health
41
Public Health
26
Capacity Building
21
Key Resources
3
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
HIV
112
TB
86
AMR
67
Mental Health
35
Pharmacy
35
COVID-19
25
NTDs
20
NCDs
20
Caregiver
12
Ebola
9
Conflict
6
Rapid Response
6
Refugee
5
Cholera
4
Planetary Health
4
Polio
3
Specific Hazards
2
Health Financing Toolbox
2
Disability
1
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial ... resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyright
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Perspectives on Drugs
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
Drug Distribution and Control: Preparation and Handling
This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
